Improving the guidelines for Informed Consent

i-CONSENT, funded by the European Union H2020 programme, aims to improve the information that patients receive from clinical studies. Within the project, a series of guidelines to improve Informed Consent process will be created, including vulnerable populations, under a gender perspective and relying on ICT tools.

The Project

Project guidelines now available!

Mar 25, 2021

The i-CONSENT Project publishes its final product: "Guidelines for tailoring the informed consent process in clinical studies" Fragment of the guidelines. The i-CONSENT Guidelines are now ready and available for academia, clinical investigators, pharmaceutical...

Biomedical research involving health data in the context pandemic: implications for informed consent

Mar 24, 2021

LUMSA University organised Monday, March 22st 2021 the last meeting of its series of encounters to discuss informed consent in pandemic situations. This one, focused on ethical and legal requirements for biomedical research involving health data in the context of...

i-CONSENT presents its guidelines to improve informed consent in clinical studies

Mar 17, 2021

The project celebrated its final event: Towards the future of informed consent in clinical research. Yesterday, the i-CONSENT team finally presented its guidelines to improve informed consent in clinical studies. After 4 years of intense work and study in the...

Visit our Twitter and get the latest content!

@ICONSENTEU

Twitter feed is not available at the moment.

i-CONSENT in Numbers

From 2017 to 2021

Partners

Million EU Funding

Countries

Years Duration

Multimedia

i-CONSENT falls under the ‘Science with and for Society’ (SWAFS) programme, which means that on of our main goals is unlocking science for use by the wider public. i-CONSENT is committed to improving citizens’ health literacy not only as a solution to make science more attractive to them but also as a way of empowering them. This section will offer visitors and stakeholders information on the project, in particular, and knowledge on clinical trials, research and ethics, in general.